)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
PolyNovo (PNV) investor relations material
PolyNovo H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary25 Aug, 2025
Executive summary
Achieved record commercial sales of $119M (A$129.2m), up 28.9% year-over-year, with strong growth in the US and international markets.
Net profit after tax reached $13.2M (A$13.2m), up 149.1% from the prior year; EBITDA rose 211.1% to $11.2M (A$11.2m).
Product innovation, regulatory approvals, and new product launches expanded the addressable market and drove adoption in new indications and geographies.
Completed enrollment and three-month data review for the BARDA pivotal clinical trial, advancing US regulatory strategy and confirming PMA submission with the FDA.
Global expansion continued, with robust sales growth in the US, EMEA, APAC, and Rest of World markets.
Financial highlights
Total revenue reached $119M (A$129.2m), up 23.3% year-over-year; commercial sales grew 28.9%, with US sales up 28.7% to $88.4M and international sales up 29.6% to $30.3M.
Net profit after tax was $13.2M (A$13.2m), a 149.1% increase; EBITDA reached $11.2M (A$11.2m), up 211.1%.
Operating profit increased 341.2% to $7.5M (A$7.5m).
Operating expenses rose 19.4%, below the rate of sales growth, improving operating leverage.
BARDA revenue declined 22.8% to $8.6M (A$8.6m) as the pivotal trial neared completion.
Outlook and guidance
Focus on disciplined execution, expanding BTM and MTX adoption, and supporting growth in new indications and geographies.
BARDA pivotal trial and PMA submission targeted for end of calendar year, with FDA review expected to take 8–12 months.
Continued investment in R&D, new product pipeline, and operational excellence initiatives to drive profitability and efficiency.
Positive cash flow and strong cash position anticipated to support growth.
Leadership transition with a new CEO and refreshed Board.
MTX's role in expanding non-burn market share?
Leveraging new capacity and cash for growth?
Cell therapy platform's commercial pathway?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next PolyNovo earnings date
AGM 202528 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
PolyNovo Limited is an Australian medical device company specializing in the development and manufacturing of advanced wound care solutions using its proprietary NovoSorb biodegradable polymer technology. The company's flagship product, NovoSorb Biodegradable Temporizing Matrix (BTM), is designed to support dermal regeneration in patients who have suffered tissue loss due to burns, trauma, or surgical procedures. NovoSorb BTM is utilized in various medical applications, including the treatment of complex wounds, chronic ulcers, and surgical wounds. Additionally, PolyNovo is expanding its product portfolio to include applications in hernia repair and other reconstructive surgeries. PolyNovo Limited is headquartered in Port Melbourne, Victoria, Australia, and its shares are listed on the Australian Securities Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage